The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

Jeffrey M. Peters, Yatrik M. Shah, Frank J. Gonzalez

Research output: Contribution to journalReview articlepeer-review

309 Scopus citations


Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

Original languageEnglish (US)
Pages (from-to)181-195
Number of pages15
JournalNature Reviews Cancer
Issue number3
StatePublished - Mar 2012

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention'. Together they form a unique fingerprint.

Cite this